{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:15:25Z","timestamp":1792275325189,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/igo\/"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["LNCC 2017"],"award-info":[{"award-number":["LNCC 2017"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["PRT-K-15-039"],"award-info":[{"award-number":["PRT-K-15-039"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ebiom.2019.09.003","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T17:04:08Z","timestamp":1571677448000},"page":"191-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"special_numbering":"C","title":["Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions"],"prefix":"10.1016","volume":"48","author":[{"given":"Nicolas","family":"Alcala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Mangiante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9522-6552","authenticated-orcid":false,"given":"Nolwenn","family":"Le-Stang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne E.","family":"Gustafson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Boyault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Damiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Alcala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Brevet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Thivolet-Bejui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Blanc-Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Le Rochais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebtane","family":"Planchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Damotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Claude","family":"Pairon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Christine","family":"Copin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Scherpereel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Wasielewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Wicquart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Lacomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Vignaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaspard","family":"Ancelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Sagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Bonnetaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Hofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Hofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Mouroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Thomas de Montpreville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Clermont-Taranchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Mazieres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Rouquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Begueret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7190-120X","authenticated-orcid":false,"given":"Jean-Yves","family":"Blay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Lantuejoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Caux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Foll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Galateau-Salle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0724-6703","authenticated-orcid":false,"given":"Lynnette","family":"Fernandez-Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2019.09.003_bb0005","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/oemed-2016-104133","article-title":"Dose-time-response association between occupational asbestos exposure and pleural mesothelioma","volume":"74","author":"Lacourt","year":"2017","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0010","series-title":"Classification of tumours of the lung, pleura, thymus and heart","author":"World Health Organization. WHO","year":"2015"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0015","article-title":"EURACAN\/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach","author":"Nicholson","year":"2019","journal-title":"J Thorac Oncol (In Press)"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0020","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jtho.2018.04.023","article-title":"New insights on diagnostic reproducibility of biphasic mesotheliomas: a multi-institutional evaluation by the international mesothelioma panel from the MESOPATH reference center","volume":"13","author":"Galateau Salle","year":"2018","journal-title":"J Thorac Oncol: Off Pub Int Assoc Study Lung Cancer"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0025","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0030","doi-asserted-by":"crossref","first-page":"S311","DOI":"10.21037\/jtd.2017.10.131","article-title":"Target therapy: new drugs or new combinations of drugs in malignant pleural mesothelioma","volume":"10","author":"Zucali","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0035","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.2017.76.6394","article-title":"Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology clinical practice guideline","volume":"36","author":"Kindler","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0040","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jtho.2018.08.2024","article-title":"Treat it or leave it: immuno-oncology in mesothelioma observed by the eyes of Argus","volume":"13","author":"de Gooijer","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0045","author":"European Society for Medical Oncology","year":"2017"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0050","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrc.2017.42","article-title":"Novel insights into mesothelioma biology and implications for therapy","volume":"17","author":"Yap","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0055","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jtho.2017.02.013","article-title":"The immune microenvironment, genome-wide copy number aberrations, and survival in mesothelioma","volume":"12","author":"Thapa","year":"2017","journal-title":"J Thorac Oncol: Off Pub Int Assoc Study Lung Cancer"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0065","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","article-title":"Integrative molecular characterization of malignant pleural mesothelioma","volume":"8","author":"Hmeljak","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0070","first-page":"51","article-title":"The French mesothelioma network from 1998 to 2013","volume":"34","author":"Galateau-Salle","year":"2014","journal-title":"Ann Pathol"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0075","first-page":"166","article-title":"HTSeq--a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics (Oxford, England)"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0080","first-page":"15","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics (Oxford, England)"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0085","series-title":"A wrapper tool around Cutadapt and FastQC to consistently apply quality and adapter trimming to FastQ files","author":"Galore","year":"2015"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0090","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","article-title":"Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data","volume":"11","author":"Finotello","year":"2019","journal-title":"Genome Med"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0095","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0100","author":"McInnes"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0105","author":"Kiefer"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13040-015-0059-z","article-title":"Principal component gene set enrichment (PCGSE)","volume":"8","author":"Frost","year":"2015","journal-title":"BioData Min"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0115","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0120","author":"Therneau"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0125","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/sj.bjc.6601120","article-title":"Survival analysis part III: multivariate data analysis -- choosing a model and assessing its adequacy and fit","volume":"89","author":"Bradburn","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0130","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1002\/sim.2299","article-title":"Estimation of time-dependent area under the ROC curve for long-term risk prediction","volume":"25","author":"Chambless","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0135","author":"Potapov"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0140","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1002\/sim.5347","article-title":"Use of alternative time scales in cox proportional hazard models: implications for time-varying environmental exposures","volume":"31","author":"Griffin","year":"2012","journal-title":"Stat Med"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0145","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B Methodol"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0150","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell."},{"key":"10.1016\/j.ebiom.2019.09.003_bb0155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cyto.2018.08.006","article-title":"Role of angiopoietins in mesothelioma progression","volume":"118","author":"Magkouta","year":"2019","journal-title":"Cytokine."},{"key":"10.1016\/j.ebiom.2019.09.003_bb0160","doi-asserted-by":"crossref","first-page":"21783","DOI":"10.18632\/oncotarget.25004","article-title":"Targeting Tie-2\/angiopoietin axis in experimental mesothelioma confers differential responses and raises predictive implications","volume":"9","author":"Magkouta","year":"2018","journal-title":"Oncotarget."},{"key":"10.1016\/j.ebiom.2019.09.003_bb0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/bjc.2017.434","article-title":"Mechanisms of resistance to immune checkpoint inhibitors","volume":"118","author":"Jenkins","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0170","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/modpathol.2011.144","article-title":"Epithelial-mesenchymal transition in malignant mesothelioma","volume":"25","author":"Fassina","year":"2012","journal-title":"Mod Pathol: Off J U S Can Acad Pathol, Inc"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0175","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ejcts.2009.08.027","article-title":"Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma","volume":"37","author":"Schramm","year":"2010","journal-title":"Eur J Cardiothorac Surg: Off J Eur Assoc Cardiothorac Surg"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2016.01.010","article-title":"Immune biomarkers PD-1\/PD-L1 and TLR3 in malignant pleural mesotheliomas","volume":"52","author":"Combaz-Lair","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0185","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1158\/0008-5472.CAN-13-1504","article-title":"VISTA is an immune checkpoint molecule for human T cells","volume":"74","author":"Lines","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0190","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1186\/s12885-018-4435-1","article-title":"VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0195","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1158\/1078-0432.CCR-17-2542","article-title":"Spatially resolved and quantitative analysis of VISTA\/PD-1H as a novel immunotherapy target in human non-small cell lung cancer","volume":"24","author":"Villarroel-Espindola","year":"2018","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0200","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/sj.bjc.6690650","article-title":"VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours","volume":"81","author":"Ohta","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0205","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.canlet.2014.08.027","article-title":"Restoration of natural killer cell cytotoxicity by VEGFR-3 inhibition in myelogenous leukemia","volume":"354","author":"Lee","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0210","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/dc.20767","article-title":"Immunohistochemical expression and distribution of VEGFR-3 in malignant mesothelioma","volume":"35","author":"Filho","year":"2007","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0215","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jtho.2016.04.028","article-title":"Consensus report of the 2015 Weinman international conference on mesothelioma","volume":"11","author":"Carbone","year":"2016","journal-title":"J Thorac Oncol: Off Pub Int Assoc Study Lung Cancer"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0220","author":"Abstract Book"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0225","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","article-title":"Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges","volume":"15","author":"Fukumura","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0230","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri.2017.145","article-title":"Improving immune-vascular crosstalk for cancer immunotherapy","volume":"18","author":"Huang","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0235","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nrclinonc.2018.9","article-title":"Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa","volume":"15","author":"Khan","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ebiom.2019.09.003_bb0240","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41419-017-0061-0","article-title":"Defining the role of the tumor vasculature in antitumor immunity and immunotherapy","volume":"9","author":"Schaaf","year":"2018","journal-title":"Cell Death Dis"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419306012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419306012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:55:37Z","timestamp":1762455337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396419306012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":48,"alternative-id":["S2352396419306012"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.09.003","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/334326","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 World Health Organization; licensee Elsevier.","name":"copyright","label":"Copyright"}]}}